Phibro acquires vaccines manufacturer

Liza Mayer
March 06, 2019
By Liza Mayer
Phibro acquires vaccines manufacturer
Credit: Adobe Stock
Phibro Animal Health Corp has acquired the assets of KoVax Ltd, an Israel-based developer and manufacturer of vaccines for the global aquaculture market.

The acquisition strengthens Phibro’s position in fish vaccine innovation and expands its portfolio of aquaculture products.

KoVax’s research and development team has joined Phibro’s biological R&D team, and will focus on developing a pipeline of innovative vaccines for the aquaculture market.

Phibro’s first commercial aquaculture vaccine is KoVax’s “KV3” vaccine, which helps prevent Koi Herpes Virus, a highly contagious disease that can cause significant mortality in common carp farms.

Add comment


Security code
Refresh

Subscription Centre

Most Popular

Latest Events

Aqua Nor
Tue Aug 20, 2019
Aquaculture Europe 2019
Mon Oct 07, 2019
EXPO PESCA & ACUIPERU
Wed Nov 06, 2019

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.